Neuroimmune communication in hypertension and obesity: A new therapeutic angle?
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Hypertension is an epidemic health concern and a major risk factor for the development of cardiovascular disease. Although there are available treatment strategies for hypertension, numerous hypertensive patients do not have their clinical symptoms under control and it is imperative that new avenues to treat or prevent high blood pressure in these patients are developed. It is well established that increases in sympathetic nervous system (SNS) outflow and enhanced renin-angiotensin system (RAS) activity are common features of hypertension and various pathological conditions that predispose individuals to hypertension. More recently, hypertension has also become recognized as an immune condition and accumulating evidence suggests that interactions between the RAS, SNS and immune systems play a role in blood pressure regulation. This review summarizes what is known about the interconnections between the RAS, SNS and immune systems in the neural regulation of blood pressure. Based on the reviewed studies, a model for RAS/neuroimmune interactions during hypertension is proposed and the therapeutic potential of targeting RAS/neuroimmune interactions in hypertensive patients is discussed. Special emphasis is placed on the applicability of the proposed model to obesity-related hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain energy metabolism: focus on Astrocyte-neuron metabolic cooperation
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.016 · Cited by 2,313
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
The sympathetic control of blood pressure
Guyenet, P. G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1902 · Cited by 1,863
Obesity is associated with hypothalamic injury in rodents and humans.
Thaler, J. P., Yi, C.-X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., Zhao, X., Sarruf, D. A., Izgur, V., Maravilla, K. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59660 · Cited by 1,857
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 6×
“In this regard, immune factors, such as TNFα (Sriramula et al., 2008; Tran et al., 2009), IL-6 (Brands et al., 2010) and T-lymphocytes (Guzik et al., 2007a; Marvar et al., 2010) are necessary for Ang-II-induced hypertension.”
BackgroundInfluentialWake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., & Nabekura, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-08.2009 · Cited by 1,619
Twenty years of research on cytokine-induced sickness behavior
Dantzer, R., & Kelley, K. W. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.006 · Cited by 1,420
Swanson, L. W., & Kuypers, H. G. J. M. (1980) · Journal of Comparative Neurology · doi:10.1002/cne.901940306 · Cited by 1,413 · cited 3×
“Neurons of the PVN are divided into distinct magnocellular and parvocellular sub-nuclei (Swanson & Kuypers, 1980).”
BackgroundInfluentialSignals from the Sympathetic Nervous System Regulate Hematopoietic Stem Cell Egress from Bone Marrow
Katayama, Y., Battista, M., Kao, W.-M., Hidalgo, A., Peired, A. J., Thomas, S. A., & Frenette, P. S. (2006) · Cell · doi:10.1016/j.cell.2005.10.041 · Cited by 1,412 · cited 2×
“Accumulating evidence suggests that the SNS regulates mobilization of microglial progenitors (Katayama et al., 2006).”
BackgroundHypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and Obesity
Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H., & Cai, D. (2008) · Cell · doi:10.1016/j.cell.2008.07.043 · Cited by 1,350
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · cited 2×
“Astrocytes buffer CNS potassium, remove excess cytotoxic glutamate and modulate blood flow (Gurden et al., 2006; Belanger et al., 2011; Ransohoff & Brown, 2012).”
BackgroundIncidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789 · cited 1×
“In this regard, obesity is a principal risk factor for the development of hypertension and these ailments are very often co-morbid (Garrison et al., 1987; Cassano et al., 1990; Brown et al., 2000; Timpson et al., 2009; Weiss et al., 2009; Armitage et al., 2012).”
BackgroundRenal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0904179 · Cited by 772 · cited 3×
“…have increased sympathetic outflow, parasympathetic withdrawal, and norepinephrine spillover, and surgical denervation of the kidney has shown promise as an effective intervention for these patients (Krum et al., 2009; Schlaich et al., 2009a, 2009b; Esler et al., 2010; Schlaich et al., 2012).”
BackgroundInflammatory pathways and insulin action
Hotamisligil, G. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802502 · Cited by 717
Turnover of resident microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., & Gordon, S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90500-2 · Cited by 709
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614 · cited 6×
“Before discussing how the RAS, SNS and immune systemsmay interact to cause hypertension, it is appropriate to first review the roles of the SNS and RAS in blood pressure regulation.”
BackgroundInfluentialPosey, K. A., Clegg, D. J., Printz, R. L., Byun, J., Morton, G. J., Vivekanandan-Giri, A., Pennathur, S., Baskin, D. G., Heinecke, J. W., Woods, S. C., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90377.2008 · Cited by 586
Blood-brain barrier transport of cytokines: a mechanism for neuropathology
Banks, W. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381684 · Cited by 534 · cited 2×
“hand regulates much of the neuroimmune exchange by serving as an intermediary for the peripheral immune system's ability to impact the brain (Banks, 2005; Banks & Erickson, 2010).”
BackgroundThe blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · cited 1×
“…brain barrier (BBB), which on one hand protects the CNS from deleterious peripheral immune reactions, on the other hand regulates much of the neuroimmune exchange by serving as an intermediary for the peripheral immune system's ability to impact the brain (Banks, 2005; Banks & Erickson, 2010).”
BackgroundRegional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3423 · Cited by 404
Neural mechanisms in human obesity-related hypertension
Rumantir, M. S., Vaz, M., Jennings, G. L., Collier, G., Kaye, D. M., Seals, D. R., Wiesner, G. H., Brunner-La Rocca, H. P., & Esler, M. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00012 · Cited by 396
Microglia: activation and their significance in the central nervous system
Nakajima, K., & Kohsaka, S. (2001) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a002969 · Cited by 371
Grassi, G., Seravalle, G., Colombo, M., Bolla, G., Cattaneo, B. M., Cavagnini, F., & Mancia, G. (1998) · Circulation · doi:10.1161/01.cir.97.20.2037 · Cited by 364 · cited 4×
“…blood pressure by elevating cardiac output, vascular ion in hypertension and obesity: A new therapeutic angle?, Pharmacol resistance and fluid retention, respectively, while inhibiting the SNS produces the opposite effects (Goldstein, 1983; Grassi, 1998; Grassi et al., 1998; Burke et al., 2012).”
BackgroundInfluentialInteractions between the melanocortin system and leptin in control of sympathetic nerve traffic
Haynes, W. G., Morgan, D. A., Djalali, A., Sivitz, W. I., & Mark, A. L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.542 · Cited by 358 · cited 1×
“…by Ang-II/AT1R specifically within the SFO (e.g., ER stress or oxidative stress) attenuates the elevated SNS activity and blood pressure that accompany experimental hypertension (Zimmerman et al., 2004a, 2004b; Hendel & Collister, 2005; Cao et al., 2012; Osborn et al., 2012; Young et al., 2012).”
BackgroundKanoski, S. E., Zhang, Y., Zheng, W., & Davidson, T. L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091414 · Cited by 324
Minireview: Inflammation and Obesity Pathogenesis: The Hypothalamus Heats Up
Thaler, J. P., & Schwartz, M. W. (2010) · Endocrinology · doi:10.1210/en.2010-0336 · Cited by 313
Liu, W., Tang, Y., & Feng, J. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.011 · Cited by 303 · cited 1×
“Moreover, astrocytes and microglia interact to regulate one another's function and the function of neurons (Kloss et al., 1997; Bezzi et al., 2001a, 2001b; Belanger et al., 2011; Liu et al., 2011).”
BackgroundMalm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301
Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease
DeWitt, D. A., Perry, G., Cohen, M., Doller, C., & Silver, J. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6738 · Cited by 261 · cited 2×
“They secrete factors that modulate the activity of microglia and they are impacted by factors secreted by microglia (DeWitt et al., 1998; Yang et al., 1998; Bezzi et al., 2001a).”
BackgroundAngiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
Benicky, J., Sánchez-Lemus, E., Honda, M., Pang, T., Orecna, M., Wang, J., Leng, Y., Chuang, D.-M., & Saavedra, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.225 · Cited by 254 · cited 2×
“In this regard, it has been hypothesized that AT1R blockade may have utility for the treatment of inflammatory brain disorders (Benicky et al., 2009; Benicky et al., 2011).”
BackgroundMark, A. L., Shaffer, R. A., Correia, M. L. G., Morgan, D. A., Sigmund, C. D., & Haynes, W. G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917121-00026 · Cited by 254 · cited 2×
“obesity (Mark et al., 1999) and it is possible that leptin is a critical mediator of obesity-related hypertension.”
BackgroundStraznicky, N. E., Lambert, E. A., Lambert, G. W., Masuo, K., Esler, M. D., & Nestel, P. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0961 · Cited by 227
Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F. Q., Bombelli, M., Scopelliti, F., Facchini, A., & Mancia, G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00027 · Cited by 225 · cited 8×
“Before discussing how the RAS, SNS and immune systemsmay interact to cause hypertension, it is appropriate to first review the roles of the SNS and RAS in blood pressure regulation.”
BackgroundInfluentialUncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB
Purkayastha, S., Zhang, G., & Cai, D. (2011) · Nature Medicine · doi:10.1038/nm.2372 · Cited by 220 · cited 3×
“…modulates the neural circuitry that controls sympathetic outflow and blood pressure and several mechanisms for the enhanced sympathetic drive during obesity have been proposed (Haynes, 2005; Stocker et al., 2006; Purkayastha et al., 2011; Hilzendeger et al., 2012; Yiannikouris et al., 2012a).”
BackgroundHypertension in Obese Zucker Rats: Role of Angiotensin II and Adrenergic Activity
Alonso-Galicia, M., Brands, M. W., Zappe, D. H., & Hall, J. E. (1996) · Hypertension · doi:10.1161/01.hyp.28.6.1047 · Cited by 200 · cited 2×
“Importantly, both pathologies are independently associated with activation of the SNS and RAS (Grassi et al., 1995, 2003; Alonso-Galicia et al., 1996; Vaz et al., 1997; Cooper et al., 1998; Rumantir et al., 1999; de Kloet et al., 2010; Armitage et al., 2012) and when obese individuals reduce…”
BackgroundAntihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects
Wofford, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01293-6 · Cited by 184 · cited 1×
“…et al., 1998; Rumantir et al., 1999; de Kloet et al., 2010; Armitage et al., 2012) and when obese individuals reduce sympathetic drive or RAS activity either pharmacologically or by losing weight, their blood pressure is decreased (Grassi et al., 1998;Wofford et al., 2001; Straznicky et al., 2005).”
BackgroundLeptin Signaling in the Nucleus Tractus Solitarii Increases Sympathetic Nerve Activity to the Kidney
Mark, A. L., Agassandian, K., Morgan, D. A., Liu, X., Cassell, M. D., & Rahmouni, K. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.124255 · Cited by 139 · cited 2×
“cular control centers of the brain to increase sympathetic outflow to several tissues (Haynes et al., 1999; Haynes, 2005; Mark et al., 2009),”
BackgroundRapid Onset of Renal Sympathetic Nerve Activation in Rabbits Fed a High-Fat Diet
Armitage, J. A., Burke, S. L., Prior, L. J., Barzel, B., Eikelis, N., Lim, K., & Head, G. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190413 · Cited by 115 · cited 8×
“Before discussing how the RAS, SNS and immune systemsmay interact to cause hypertension, it is appropriate to first review the roles of the SNS and RAS in blood pressure regulation.”
BackgroundInfluentialGetting away from glucose: fanning the flames of obesity-induced inflammation
Shoelson, S. E., & Goldfine, A. B. (2009) · Nature Medicine · doi:10.1038/nm0409-373 · Cited by 98
T Lymphocytes and Vascular Inflammation Contribute to Stress-Dependent Hypertension
Marvar, P. J., Vinh, A., Thabet, S., Lob, H. E., Geem, D., Ressler, K. J., & Harrison, D. G. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.017 · Cited by 89
Innate immune responses in central nervous system inflammation
Finsen, B., & Owens, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.030 · Cited by 50 · cited 1×
“Astrocytes also express AT1R and Ang-II can elicit immune responses via their activation (Kandalam & Clark, 2010; Finsen & Owens, 2011; Fuchtbauer et al., 2011).”
Background
Cited by
The pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
Brain inflammation and hypertension: the chicken or the egg?
Winklewski, P. J., Radkowski, M., Wszedybyl-Winklewska, M., & Demkow, U. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0306-8 · Cited by 116
de Kloet, A. D., Pioquinto, D. J., Nguyen, D., Wang, L., Smith, J. A., Hiller, H., & Sumners, C. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.01.016 · Cited by 66
Self-citationde Kloet, A. D., Liu, M., Rodríguez, V., Krause, E. G., & Sumners, C. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00078.2015 · Cited by 64
“One mechanism by which the various neuronal and glial cell types of the brain communicate with one another is via the release and detection of proinflammatory or immune factors (39).”
BackgroundMethodSelf-citation
Metadata
- Authors
- de Kloet, A. D., Krause, E. G., Shi, P. D., Zubcevic, J., Raizada, M. K., & Sumners, C.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 138
- Issue
- 3
- Pages
- 428-440
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2046602956
- Cited by
- 46
- References
- 45
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.